Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Deloitte
US Army
Novartis
Cipla
Mallinckrodt
Citi
QuintilesIMS
US Department of Justice
Boehringer Ingelheim

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,387,946

« Back to Dashboard

Summary for Patent: 6,387,946
Title: Methods for treating pathological conditions of abnormal cell proliferation
Abstract:New taxoids of general formula (I): ##STR1## their preparation and pharmaceutical compositions containing them. The new products of general formula (I) in which Z represents a radical of general formula (II): ##STR2## display noteworthy antitumour and antileukaemic properties.
Inventor(s): Bouchard; Herve (Ivry-sur-Seine, FR), Bourzat; Jean-Dominique (Vincennes, FR), Commer.cedilla.on; Alain (Vitry-sur-Seine, FR)
Assignee: Aventis Pharma S.A. (Antony, FR)
Application Number:09/985,956
Patent Claim Types:
see list of patent claims
Use; Compound;

Drugs Protected by US Patent 6,387,946

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,387,946

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France95 03545Mar 27, 1995
France95 15381Dec 22, 1995

International Patents Family Members for US Patent 6,387,946

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 753 ➤ Subscribe
African Regional IP Organization (ARIPO) 785 ➤ Subscribe
African Regional IP Organization (ARIPO) 9701090 ➤ Subscribe
African Regional IP Organization (ARIPO) 9701093 ➤ Subscribe
Argentina 001440 ➤ Subscribe
Austria 185562 ➤ Subscribe
Austria 188471 ➤ Subscribe
Austria 334115 ➤ Subscribe
Australia 5278096 ➤ Subscribe
Australia 5278196 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cerilliant
Healthtrust
Accenture
Julphar
Boehringer Ingelheim
QuintilesIMS
Farmers Insurance
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot